MEDANNEX LTD has a total of 19 patent applications. It increased the IP activity by 1100.0%. Its first patent ever was published in 2017. It filed its patents most often in United Kingdom, Australia and Canada. Its main competitors in its focus markets pharmaceuticals and biotechnology are BIOCAD CJSC, BIO DISCOVERY LTD and BONNY CHRISTOPHE.
# | Country | Total Patents | |
---|---|---|---|
#1 | United Kingdom | 4 | |
#2 | Australia | 2 | |
#3 | Canada | 2 | |
#4 | Israel | 2 | |
#5 | WIPO (World Intellectual Property Organization) | 2 | |
#6 | Brazil | 1 | |
#7 | China | 1 | |
#8 | EPO (European Patent Office) | 1 | |
#9 | Republic of Korea | 1 | |
#10 | Mexico | 1 | |
#11 | Taiwan | 1 | |
#12 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Wood Christopher Barry | 11 |
#2 | Hays Henry Charles Wilson | 7 |
#3 | Flatau Tina Caroline | 7 |
#4 | Dempsey Fiona | 4 |
#5 | Crichton Scott | 4 |
#6 | Flatau Tina C | 4 |
#7 | Christopher Barry Wood | 4 |
#8 | Henry Charles Wilson Hays | 3 |
#9 | Tina Caroline Flatau | 3 |
#10 | Tina C Flatau | 1 |
Publication | Filing date | Title |
---|---|---|
GB201813136D0 | Antibody for ovarian cancer treatment | |
GB201813138D0 | Cancer treatment with an antibody | |
GB201813137D0 | Cancer treatment with an antibody | |
GB201702091D0 | Specific binding molecules |